Journal of International Oncology››2014,Vol. 41››Issue (8): 628-632.doi:10.3760/cma.j.issn.1673-422X.2014.08.021
Previous ArticlesNext Articles
Jiang Hongwei, Wang Ju, Li Haijun, Peng Jikui, Gao Xiaoping, Chen Feng
Received:
2014-01-02Revised:
2014-04-02Online:
2014-08-15Published:
2014-08-14Contact:
Jiang Hongwei E-mail:jhww2009@163.comJiang Hongwei, Wang Ju, Li Haijun, Peng Jikui, Gao Xiaoping, Chen Feng. Effects of DCC gene on biological behaviors of colorectal carcinoma cell line SW1116[J]. Journal of International Oncology, 2014, 41(8): 628-632.
[1] Defacque H, Egeberg M, Habermann A, et al. Involvement of ezrin/moesin in de novo actin assembly on phagosomal membranes[J]. EMBO J, 2000, 19(2): 199-212. [2] Dard N, Louvet S, SantaMaria A, et al. In vivo functional analysis of ezrin during mouse blastocyst formation[J]. Dev Biol, 2001, 233(1): 161-173. [3] 李佩玲, 胡春杰, 李长民, 等. 脂质体介导的DCC基因对卵巢上皮性癌细胞生长的抑制作用[J]. 中华妇产科杂志, 2006, 41(3): 186-189. [4] Martin M, SimonAssmann P, Kedinger M, et al. DCC regulates cell adhesion in human colon cancer derived HT29 cells and associates with ezrin[J]. Eur J Cell Biol, 2010, 85(8): 769-783. [5] Dickson TC, Mintz CD, Benson DL, et al. Functional binding interaction identified between the axonal CAM L1 and members of the ERM family[J]. J Cell Biol, 2002, 157(7): 1105-1112. [6] Elliott BE, Meens JA, SenGupta SK, et al. The membrane cytoskeletal crosslinker ezrin is required for metastasis of breast carcinoma cells[J]. Breast Cancer Res, 2005, 7(3): R365-373. [7] Forcet C, Stein E, Pays L, et al. Netrin1mediated axon outgrowth requires deleted in colorectal cancerdependent MAPK activation[J]. Nature, 2002, 41(7): 443-447. [8] Gautreau A, Louvard D, Arpin M. ERM proteins and NF2 tumor suppressor: the Yin and Yang of cortical actin organization and cell growth signaling[J]. Curr Opin Cell Biol, 2002, 14(1): 104-109. |
[1] | Zhang Rui, Chu Yanliu.Research progress of colorectal cancer risk assessment models based on FIT and gut microbiota[J]. Journal of International Oncology, 2024, 51(6): 370-375. |
[2] | Gao Fan, Wang Ping, Du Chao, Chu Yanliu.Research progress on intestinal flora and non-surgical treatment of the colorectal cancer[J]. Journal of International Oncology, 2024, 51(6): 376-381. |
[3] | Wang Junyi, Hong Kaibin, Ji Rongjia, Chen Dachao.Effect of cancer nodules on liver metastases after radical resection of colorectal cancer[J]. Journal of International Oncology, 2024, 51(5): 280-285. |
[4] | Sun Guobao, Yang Qian, Zhuang Qingchun, Gao Binbin, Sun Xiaogang, Song Wei, Sha Dan.Research progress on the histopathological growth patterns of colorectal liver metastasis[J]. Journal of International Oncology, 2024, 51(2): 114-118. |
[5] | Liu Debao, Sun Ziwen, Lu Shoutang, Xu Haidong.Expression and clinical significance of ASB6 in colorectal cancer tissues[J]. Journal of International Oncology, 2023, 50(8): 470-474. |
[6] | Chen Zhuo, Tao Jun, Chen Lin, Ke Jing.Value of detection of peripheral blood miR-194 combined with fecal miR-143 in the clinical screening of colorectal cancer[J]. Journal of International Oncology, 2023, 50(5): 268-273. |
[7] | Huang Zhen, Zhang Caiyutian, Ke Shaobo, Shi Wei, Zhao Wensi, Chen Yongshun.Construction of postoperative prognosis model for patients with colorectal cancer[J]. Journal of International Oncology, 2023, 50(3): 157-163. |
[8] | Xu Liangfu, Li Yuanfei.Research progress on tumor microenvironment and immune combination therapy of MSS colorectal cancer[J]. Journal of International Oncology, 2023, 50(3): 186-190. |
[9] | Liu Yujie, Zhao Zhiqiang, Wang Zicheng.Levels and diagnostic value of TOP2A and ERBB2 in peripheral blood mononuclear cells of patients with early colorectal cancer[J]. Journal of International Oncology, 2023, 50(12): 717-722. |
[10] | Tao Hong, Yin Hong, Luo Hong, Tao Jiayu.Potential strategies for targeting tumor-associated macrophages to enhance the efficacy of immune checkpoint inhibitors for colorectal cancer[J]. Journal of International Oncology, 2023, 50(11): 683-687. |
[11] | Wang Xi, Wu Chuanqing.Research progress in reversing multidrug resistance in colorectal cancer[J]. Journal of International Oncology, 2023, 50(1): 42-46. |
[12] | Gao Yizhao, Liu Yang, Liu Qiulong, Xing Jinliang.Application of circulating cell-free nucleic acid in clinical diagnosis and treatment of colorectal cancer[J]. Journal of International Oncology, 2022, 49(9): 555-559. |
[13] | He Zhefeng, Wu Yiyang, Li Zhenjun, Ying Xiaojiang.Predictive value of inflammatory markers in colorectal cancer[J]. Journal of International Oncology, 2022, 49(9): 560-563. |
[14] | Zhao Ying, Zhang Gehong.Study on the correlations between AGR, PLR and NLR changes and chemotherapy efficacy of metastatic colorectal cancer[J]. Journal of International Oncology, 2022, 49(8): 473-477. |
[15] | Huang Mengpan, Wang Xuehong, Lu Yongfu.Mechanism of FOXA2 in colorectal cancer and its application in diagnosis and treatment[J]. Journal of International Oncology, 2022, 49(8): 490-493. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||